Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Cytomegalovirus and herpesvirus research, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Herpesvirus Infections and Treatments.
A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
Second multistate outbreak of tuberculosis caused by a bone allograft product
Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study.
American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research.
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease
Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing.
Ten years of donor-derived disease: A report of the disease transmission advisory committee.
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients.
Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
Comparison of standard versus low-dose valganciclovir regimens for cytomegalovirus prophylaxis in high-risk liver transplant recipients.
Increasing net immunosuppression after BK polyoma virus infection.
Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
Macrolide‐resistant <i>Mycoplasma pneumoniae</i> pneumonia in transplantation: Increasingly typical?
Human T-cell lymphotrophic virus in solid-organ transplant recipients: Guidelines from the American society of transplantation infectious diseases community of practice.
<i>Rhodococcus</i>Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1
Current practices for treatment of respiratory syncytial virus and other non‐influenza respiratory viruses in high‐risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors
Donor-Derived Transmission Events in 2013
Considerations for Screening Live Kidney Donors for Endemic Infections: A Viewpoint on the UNOS Policy
Communication Gaps Associated With Donor-Derived Infections
Histoplasmosis After Solid Organ Transplant
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study